Scholar Rock

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Scholar Rock 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About SRRK

Scholar Rock Holding Corp. is a biopharmaceutical company. It engages in the business of discovering, developing, and delivering innovative medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. 

CEO
David L. Hallal
CEODavid L. Hallal
Employees
196
Employees196
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2012
Founded2012
Employees
196
Employees196

SRRK Key Statistics

Market cap
3.60B
Market cap3.60B
Price-Earnings ratio
-12.40
Price-Earnings ratio-12.40
Dividend yield
Dividend yield
Average volume
2.07M
Average volume2.07M
High today
$39.50
High today$39.50
Low today
$29.41
Low today$29.41
Open price
$34.76
Open price$34.76
Volume
7.13M
Volume7.13M
52 Week high
$46.98
52 Week high$46.98
52 Week low
$22.71
52 Week low$22.71

Stock Snapshot

The current Scholar Rock(SRRK) stock price is $37.35, with a market capitalization of 3.6B. The stock trades at a price-to-earnings (P/E) ratio of -12.40.

On 2025-11-16, Scholar Rock(SRRK) stock moved within a range of $29.41 to $39.50. With shares now at $37.35, the stock is trading +27.0% above its intraday low and -5.4% below the session's peak.

Trading volume for Scholar Rock(SRRK) stock has reached 7.13M, versus its average volume of 2.07M.

The stock's 52-week range extends from a low of $22.71 to a high of $46.98.

The stock's 52-week range extends from a low of $22.71 to a high of $46.98.

SRRK News

TipRanks 1d
Scholar Rock Advances SMA Treatment Amid Financial Losses

Scholar Rock Holding ( (SRRK) ) has released its Q3 earnings. Here is a breakdown of the information Scholar Rock Holding presented to its investors. Meet Your...

Seeking Alpha 1d
Scholar Rock outlines 2026 apitegromab launch plan and accelerates supply chain redundancy amid regulatory review

Earnings Call Insights Scholar Rock outlines 2026 apitegromab launch plan and accelerates supply chain redundancy amid regulatory review Nov. 14, 2025 2:02 PM E...

Scholar Rock outlines 2026 apitegromab launch plan and accelerates supply chain redundancy amid regulatory review
Benzinga 1d
Why Is Scholar Rock Holding Stock Climbing Today?

Scholar Rock Holding Corporation (NASDAQ:SRRK) traded higher on Friday after the biotechnology company posted quarterly results and outlined updated financial r...

Why Is Scholar Rock Holding Stock Climbing Today?

Analyst ratings

100%

of 13 ratings
Buy
100%
Hold
0%
Sell
0%

More SRRK News

TipRanks 2d
SRRK Earnings: Scholar Rock Stock Soars on FDA Meeting Despite Q3 Miss

Scholar Rock (SRRK) stock soared on Friday after the biotechnology company released its Q3 2025 earnings report. The company reported earnings per share of -90...

TipRanks 2d
Scholar Rock Announces $200M At-The-Market Offering

Meet Your ETF AI Analyst Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions AI Analyst can help you make smarter investment...

Simply Wall St 3d
Has Scholar Rock’s Clinical Progress Sparked a Real Opportunity Following Recent 10% Price Jump?

Wondering if Scholar Rock Holding could be an undervalued opportunity or if the recent excitement is just noise? You're not alone. Let's dig in and see what the...

Has Scholar Rock’s Clinical Progress Sparked a Real Opportunity Following Recent 10% Price Jump?

People also own

Based on the portfolios of people who own SRRK. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.